DN

DNA Group (T.R.) Ltd.

DNA | TA

Overview

Corporate Details

ISIN(s):
IL0011038523
LEI:
Country:
Israel
Address:
Shimon Hatars' 43, 6249245 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

DNA Group develops and markets technological solutions for defense and homeland security sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-11-06 14:35
Regulatory News Service
Changes in the company's names and security names , effective as of f November …
Hebrew (modern) 149.0 KB
2021-07-29 21:13
Regulatory News Service
Termination of coverage report
Hebrew (modern) 174.5 KB
2021-07-29 21:13
Notice of Dividend Amount
Termination of coverage report
Russian 101.2 KB
2021-06-13 10:10
Regulatory News Service
update Analysis (FROST) following financial report, target price remains at NIS…
English 1.1 MB
2021-06-13 10:10
Investor Presentation
update Analysis (FROST) following financial report, target price remains at NIS…
Russian 101.2 KB
2021-04-11 22:23
Earnings Release
update Analysis (FROST) following financial report 2020,target price remains at…
English 1.1 MB
2021-04-11 22:23
Pre-Annual General Meeting Information
update Analysis (FROST) following financial report 2020,target price remains at…
Russian 98.1 KB
2020-12-16 19:22
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
English 1.1 MB
2020-12-16 19:22
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
Russian 94.7 KB
2020-09-01 21:58
Regulatory News Service
Analysis update following financial report:price target is unchanged NIS 2.62
English 1.1 MB
2020-09-01 21:58
Environmental & Social Information
Analysis update following financial report:price target is unchanged NIS 2.62
Russian 94.7 KB
2020-08-24 21:06
Earnings Release
update analsis (FORST),price target is unchanged
English 1.1 MB
2020-08-24 21:06
Investor Presentation
update analsis (FORST),price target is unchanged
Russian 91.4 KB
2020-06-10 21:16
Investor Presentation
Quarterly analysis update report
English 1.1 MB
2020-06-10 21:16
Investor Presentation
Quarterly analysis update report
Russian 93.5 KB

Automate Your Workflow. Get a real-time feed of all DNA Group (T.R.) Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DNA Group (T.R.) Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Molecular Partners AG Logo
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland MOLN
MorphoSys AG Logo
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany MOR
Mycodern Spolka Akcyjna Logo Poland MCD
N4 PHARMA PLC Logo
Developing a nanoparticle delivery system for advanced gene and vaccine therapies.
United Kingdom N4P
NextGen Biomed Ltd. Logo
R&D of biotech medical devices for diabetes care and topical skin treatments.
Israel NXGN
Nicox S.A. Logo
Developing innovative ophthalmology drugs for glaucoma and ocular hypertension.
France COX
ONCIMMUNE HOLDINGS PLC Logo
Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.
United Kingdom ONC
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden ONCOZ

Talk to a Data Expert

Have a question? We'll get back to you promptly.